• Expanding the Diversity at the C-4 Position of Pyrido[2,3-d]pyrimidin-7(8H)-ones to Achieve Biological Activity against ZAP-70 

  Masip, Victor; Lirio, Ángel; López-Huertas, Albert; Cuenca, Ana Belen; Puig de la Bellacasa, Raimon; Abrisqueta Costa, Pablo (MDPI, 2021-12-15)

• Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study 

  Tempero, Margaret A.; Oh, Do-Youn; Tabernero Caturla, Josep; Reni, Michele; Van Cutsem, Eric; Hendifar, Andrew E.; Macarulla Mercadé, Teresa (Elsevier, 2021-05)

• Tumor-Associated Microbiome: Where Do We Stand? 

  Oliva, Marc; Mulet Margalef, Núria; Ochoa de Olza, Maria; Napoli, Stefania; Mas Lloret, Joan; Laquente, Berta; Nuciforo, Paolo Giovanni (MDPI, 2021-02-01)

• Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer 

  Saura Manich, Cristina; Matito Ariza, Judit; Antunes de Melo Oliveira, Ana Mafalda; Wildiers, Hans; Brufksy, Adam M.; Waters, Simon; Vivancos Prellezo, Ana (American Association for Cancer Research, 2021-11-01)

• Feasibility of Data-Driven, Model-Free Quantitative MRI Protocol Design: Application to Brain and Prostate Diffusion-Relaxation Imaging 

  Grussu, Francesco; Blumberg, Stefano B.; Battiston, Marco; Kakkar, Lebina S.; Lin, Hongxiang; Ianus, Andrada (Frontiers Media, 2021-11)

View more